Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Debt to Equity: 2011-2012

Historic Debt to Equity for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$3.73.

  • Sonoma Pharmaceuticals' Debt to Equity fell 97.49% to $0.50 in Q4 2012 from the same period last year, while for Dec 2012 it was $0.50, marking a year-over-year decrease of 99.28%. This contributed to the annual value of -$3.73 for FY2012, which is 349.41% down from last year.
  • As of FY2012, Sonoma Pharmaceuticals' Debt to Equity stood at -$3.73, which was down 349.41% from $1.50 recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' Debt to Equity ranged from a high of $1.50 in FY2011 and a low of -$3.73 during FY2012.
  • Its 2-year average for Debt to Equity is -$1.12, with a median of -$1.12 in 2011.
  • Data for Sonoma Pharmaceuticals' Debt to Equity shows a maximum YoY crashed of 349.41% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Debt to Equity (Yearly) stood at $1.50 in 2011, then slumped by 349.41% to -$3.73 in 2012.